Results 151 to 160 of about 8,130 (203)

Optimizing human FcRn mouse models to improve pharmacokinetic evaluation of antibody drug candidates. [PDF]

MAbs
Christianson G, Howard ZM, Kenney S, Lowell E, Bethur N, Roopenian D, Gonzalo-Gil E.   +6 more
europepmc   +1 more source

Immunoglobulin G Fc engineering for localized therapy: Eliminating neonatal Fc receptor interactions and ensuring purification using protein A. [PDF]

Protein Sci
Kato A, Toshima A, Takekawa G, Miyagi H, Kubota A, Hori S, Uemura Y, Niwa R.   +7 more
europepmc   +1 more source

Polypharmacology of S-1117, an Fc-fused IgG-selective degrading enzyme, for chronic treatment of autoantibody-mediated diseases. [PDF]

Proc Natl Acad Sci U S A
Sanmarco LM, Pellerin A, Green T, Plasencia A, Anderson JM, Le N, Newton A, Chen J, Ramello MC, Peckner R, Manasson J, Xing Y, Vital H, Higginson-Scott N, Sundy JS, Otipoby KL, Mascanfroni ID.   +16 more
europepmc   +1 more source

Temporal dynamics of IgG-mediated immunometabolic dysfunction: from acute obesity to chronic aging. [PDF]

Front Immunol
Kim S, Kim J, Lee HL, Kim MS.
europepmc   +1 more source

New perspectives on fetal and neonatal alloimmune thrombocytopenia for obstetricians. [PDF]

Front Immunol
Zhao Y, Liu P, Chen L, Ibeh CO, Kwak-Kim J, Guo F, Yang X.   +6 more
europepmc   +1 more source

Does the Chimerization Process Affect the Immunochemical Properties of WNV-Neutralizing Antibody 900? [PDF]

Int J Mol Sci
Isaeva AA, Nesmeyanova VS, Shanshin DV, Ushkalenko ND, Volosnikova EA, Esina TI, Protopopova EV, Svyatchenko VA, Loktev VB, Olkin SE, Danilenko ED, Kazachinskaia EI, Shcherbakov DN.   +12 more
europepmc   +1 more source

Development of tCAP(N3): Affinity Peptide-Aided, pH-Triggered Strategy for Site-Specific Native IgG Modification. [PDF]

Chemistry
Kawakami H, Rafique A, Tsuda S, Nagashima A, Nohara Y, Dozono N, Sakamoto K, Masuda S, Kiyoshi M, Shibata H, Ishii-Watabe A, Yoshiya T, Ito Y.   +12 more
europepmc   +1 more source

Efgartigimod as Fast-Acting Rescue Therapy in Very Late-Onset Myasthenia Gravis. [PDF]

Neurol Ther
Rini N, D'Amico F, Portera V, Brighina F, Di Stefano V.   +4 more
europepmc   +1 more source

Preclinical evaluation of an mRNA-LNPs vaccine for mucosal protection against dental caries. [PDF]

Front Microbiol
Zhou Y, Shi H, Guo Q, Li Y, Lv L, Hou L, Geng C, Wang D, Yu S, Ma S, Li Y, Sun Z, Li C.   +12 more
europepmc   +1 more source

Immunotherapy in Chronic Inflammatory Demyelinating Polyneuropathy and the Emerging Role of Efgartigimod. [PDF]

J Clin Neurol
Park JS, Kang M.
europepmc   +1 more source